title: The impact of omega-3 fatty acids on depressive disorders and suicidality: can we reconcile 2 studies with seemingly contradictory results?
authors.forename: David
authors.initials: D
authors.lastname: Mischoulon
mesh_terms: D001714:Bipolar Disorder / Q000188:drug therapy*; D000529:Complementary Therapies / Q000379:methods*; D003866:Depressive Disorder / Q000188:drug therapy*; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000628:therapy*; D004281:Docosahexaenoic Acids / Q000097:blood*; D015118:Eicosapentaenoic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D015525:Fatty Acids, Omega-3 / Q000097:blood* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000517:prevention & control*; D008889:Military Personnel / Q000523:psychology*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013405:Suicide
chemical_list: D015525:Fatty Acids, Omega-3; D010975:Platelet Aggregation Inhibitors; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid